The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder
Open accessAbstract
The P2RX7 gene is located within a region on chromosome 12q24.31 that has been identified as a susceptibility locus for affective disorders by linkage and association studies. P2RX7 is a purinergic ATP-binding calcium channel expressed in neurons as well as in microglial cells in various brain regions. We investigated 29 single nucleotide polymorphisms (SNPs) within the P2RX7 gene and adjacent genes in a sample of 1000 German Caucasian patients suffering from recurrent major depressive disorder (MDD). These were contrasted with diagnosed healthy Caucasian controls from the same population (n=1029). A non-synonymous coding SNP in the P2RX7 gene (rs2230912), previously found to be associated with bipolar disorder, was significantly associated (P=0.0019) with MDD. This polymorphism results in an amino acid exchange in the C-terminal cytosolic domain of the P2RX7 channel protein, suggesting that the observed P2RX7 polymorphism might play a causal role in the development of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The polymorphism causes an amino acid exchange from glutamine to arginine at position 460 (Gln460Arg) at long intracellular C-terminal domain of P2X7R, which have been suggested to affect both Ca2+ influx, P2RX7dimerization, and other protein—protein interactions having effects upon P2RX7-mediated signaling [71].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [71]
In the citing paper
“Lucae et al. (2006) were the first to show the association of the non-synonymous coding single nucleotide polymorphisms (SNP) rs2230912 in the P2X7R gene with MDD [71].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The Structure of Haplotype Blocks in the Human Genome
Gabriel, S. B., Schaffner, S. F., Nguyen, H., Moore, J. M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., et al. (2002) · Science · doi:10.1126/science.1069424 · Cited by 5,863
Genetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
Linkage disequilibrium in finite populations
Hill, W. G., & Robertson, A. (1968) · Theoretical and Applied Genetics · doi:10.1007/bf01245622 · Cited by 2,035
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739
A Note on Exact Tests of Hardy-Weinberg Equilibrium
Wigginton, J. E., Cutler, D. J., & Abecasis, G. R. (2005) · The American Journal of Human Genetics · doi:10.1086/429864 · Cited by 1,492
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.979 · Cited by 1,485 · cited 1×
“Major depressive disorder (MDD) and bipolar disorder (BP) are common psychiatric diseases with lifetime prevalence rates of 16–17% for MDD (1,2) and 1–3.”
BackgroundJACOBI, F., WITTCHEN, H.-U., HÖLTING, C., HÖFLER, M., PFISTER, H., MÜLLER, N., & LIEB, R. (2004) · Psychological Medicine · doi:10.1017/s0033291703001399 · Cited by 1,097
Research works printed but not linked: 1
- Suzuki, 2004, Mechanism of neuroprotection mediated by P2X(7) receptor-activated microglia, J. Pharmacol. Sci., 94, 300P
Cited by
Sorted by citations
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,962
Physiology and Pathophysiology of Purinergic Neurotransmission
Burnstock, G. (2007) · Physiological Reviews · doi:10.1152/physrev.00043.2006 · Cited by 1,609
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Purinergic signalling in the nervous system: an overview
Abbracchio, M. P., Burnstock, G., Verkhratsky, A., & Zimmermann, H. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.10.001 · Cited by 888
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
Study, L. C., Köttgen, A., Albrecht, E., Teumer, A., Vitart, V., Krumsiek, J., Hundertmark, C., Pistis, G., Ruggiero, D., O’Seaghdha, C. M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2500 · Cited by 834
Integrating neuroimmune systems in the neurobiology of depression
Wohleb, E. S., Franklin, T., Iwata, M., & Duman, R. S. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.69 · Cited by 668
Purinergic signalling and disorders of the central nervous system
Burnstock, G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2605 · Cited by 662
The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses
Iwata, M., Ota, K. T., & Duman, R. S. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.12.008 · Cited by 580
Meta-analyses of genetic studies on major depressive disorder
López‐León, S., Janssens, A. C. J. W., Ladd, A. M. G., Del‐Favero, J., Claes, S. J., Oostra, B. A., & van Duijn, C. M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002088 · Cited by 505
Bidirectional Microglia–Neuron Communication in Health and Disease
Szepesi, Z., Manouchehrian, O., Bachiller, S., & Deierborg, T. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00323 · Cited by 459
Pan, Y., Chen, X.-Y., Zhang, Q.-Y., & Kong, L.-D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.04.007 · Cited by 405
Purinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illés, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 402
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 409
Iwata, M., Ota, K. T., Li, X.-Y., Sakaue, F., Li, N., Dutheil, S., Banasr, M., Duric, V., Yamanashi, T., Kaneko, K., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.026 · Cited by 387
Microglia: Architects of the Developing Nervous System
Frost, J. L., & Schafer, D. P. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.02.006 · Cited by 385
The P2X 7 purinergic receptor: from physiology to neurological disorders
Skaper, S. D., Debetto, P., & Giusti, P. (2009) · The FASEB Journal · doi:10.1096/fj.09-138883 · Cited by 340
Yue, N., Huang, H., Zhu, X., Han, Q., Wang, Y., Li, B., Liu, Q., Wu, G., Zhang, Y., & Yu, J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0865-y · Cited by 334
Poor replication of candidate genes for major depressive disorder using genome-wide association data
Bosker, F. J., Hartman, C. A., Nolte, I. M., Prins, B. P., Terpstra, P., Posthuma, D., van Veen, T., Willemsen, G., DeRijk, R. H., de Geus, E. J., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.38 · Cited by 309
Steiger, A., & Pawlowski, M. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030607 · Cited by 333
The role of the innate immune system in psychiatric disorders
Jones, K. A., & Thomsen, C. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.002 · Cited by 274
Heterogeneity of DSM-IV Major Depressive Disorder as a Consequence of Subthreshold Bipolarity
Zimmermann, P., Brückl, T. M., Nocon, A., Pfister, H., Lieb, R., Wïttchen, H., Holsboer, F., & Angst, J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.158 · Cited by 266
ATP as a multi-target danger signal in the brain
Rodrigues, R. J., Tomé, Â. R., & Cunha, R. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00148 · Cited by 276
P2X7 Receptors: Channels, Pores and More
Volonté, C., Apolloni, S., Skaper, S. D., & Burnstock, G. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712803581137 · Cited by 259
P2X7 receptor and the NLRP3 inflammasome: Partners in crime
Pelegrín, P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114385 · Cited by 253
Arulkumaran, N., Unwin, R. J., & Tam, F. W. K. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.578068 · Cited by 254
The Neuronal Transporter Gene SLC6A15 Confers Risk to Major Depression
Kohli, M. A., Lucae, S., Saemann, P. G., Schmidt, M. V., Demirkan, A., Hek, K., Czamara, D., Alexander, M., Salyakina, D., Ripke, S., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.005 · Cited by 228
Basso, A. M., Bratcher, N. A., Harris, R. R., Jarvis, M. F., Decker, M. W., & Rueter, L. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.018 · Cited by 224
Molecular and functional properties of P2X receptors—recent progress and persisting challenges
Kaczmarek-Hájek, K., Lörinczi, É., Hausmann, R., & Nicke, A. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9314-7 · Cited by 237
P2X7 Interactions and Signaling – Making Head or Tail of It
Kopp, R., Krautloher, A., Ramírez-Fernández, A., & Nicke, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00183 · Cited by 217
P2X Receptors in Health and Disease
Burnstock, G., & Kennedy, C. (2011) · Advances in Pharmacology · doi:10.1016/b978-0-12-385526-8.00011-4 · Cited by 213
Depression and sterile inflammation: essential role of danger associated molecular patterns
Franklin, T. C., Xu, C., & Duman, R. S. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.10.025 · Cited by 204
Purinergic signalling in inflammation of the central nervous system
Virgilio, F. D., Ceruti, S., Bramanti, P., & Abbracchio, M. P. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.003 · Cited by 213
Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden
Westman, J., Hällgren, J., Wahlbeck, K., Erlinge, D., Alfredsson, L., & Ösby, U. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002373 · Cited by 204
Bhattacharya, A., Wang, Q., Ao, H., Shoblock, J. R., Lord, B., Aluisio, L. E., Fraser, I. C., Nepomuceno, D. H., Neff, R. A., Welty, N., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12314 · Cited by 204
Adenosine and ATP Receptors in the Brain
Burnstock, G., Fredholm, B. B., & Verkhratsky, A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347627 · Cited by 194
Deussing, J. M. (2006) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2006.11.003 · Cited by 197
Nicke, A., Kuan, Y., Masin, M., Rettinger, J., Marquez-Klaka, B., Bender, O., Górecki, D. C., Murrell‐Lagnado, R. D., & Soto, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033134 · Cited by 187
Horstmann, S., Lucae, S., Menke, A., Hennings, J. M., Ising, M., Roeske, D., Müller-Myhsok, B., Holsboer, F., & Binder, E. B. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.180 · Cited by 186
Microglia as modulators of cognition and neuropsychiatric disorders
Blank, T., & Prinz, M. (2012) · Glia · doi:10.1002/glia.22372 · Cited by 195
Stokes, L., Fuller, S. J., Sluyter, R., Skarratt, K. K., Gu, B. J., & Wiley, J. S. (2010) · The FASEB Journal · doi:10.1096/fj.09-150862 · Cited by 174
The P2X7 Receptor: Central Hub of Brain Diseases
Andrejew, R., Oliveira-Giacomelli, Á., Ribeiro, D. E., Glaser, T., Arnaud-Sampaio, V. F., Lameu, C., & Ulrich, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00124 · Cited by 162
Ullrich (2018) · doi:10.1038/mp.2017.188 · Cited by 145
Significance of P2X7 Receptor Variants to Human Health and Disease
Sluyter, R., & Stokes, L. (2011) · Recent Patents on DNA & Gene Sequences · doi:10.2174/187221511794839219 · Cited by 147
Stress induced microglial activation contributes to depression
Li, B., Yang, W., Ge, T., Wang, Y., & Cui, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106145 · Cited by 151
Lavebratt, C., Åberg, E., Sjöholm, L. K., & Forsell, Y. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.113 · Cited by 142
Territo, P. R., Meyer, J. A., Peters, J. S., Riley, A. K., McCarthy, B. P., Gao, M., Wang, M., Green, M. A., Zheng, Q., & Hutchins, G. D. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.181354 · Cited by 138
Machado‐Vieira, R., Soares, J. C., Lara, D. R., Luckenbaugh, D. A., Busnello, J. V., Marca, G., Cunha, A. B. M., Souza, D. O., Zarate, C. A., & Kapczinski, F. P. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0806 · Cited by 132
Roger, S., Mei, Z.-Z., Baldwin, J. M., Dong, L., Bradley, H., Baldwin, S. A., Surprenant, A., & Jiang, L. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.10.005 · Cited by 139
P2X7 Receptor Signaling in Stress and Depression
Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G., & Joca, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112778 · Cited by 129
Csölle, C., Baranyi, M., Zsilla, G., Kittel, Á., Gölöncsér, F., Illes, P., Papp, E., Vizi, E. S., & Sperlágh, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066547 · Cited by 128
Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics
Ortiz, R., Ulrich, H., Zarate, C. A., & Machado‐Vieira, R. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.10.016 · Cited by 129
Genetics of the P2X7 receptor and human disease
Fuller, S. J., Stokes, L., Skarratt, K. K., Gu, B. J., & Wiley, J. S. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9136-4 · Cited by 125
Genetics of stress response and stress-related disorders
Ising, M., & Holsboer, F. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/mising · Cited by 118
McQuillin, A., Bass, N. J., Choudhury, K., Puri, V., Kosmin, M., Lawrence, J., Curtis, D., & Gurling, H. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.6 · Cited by 117
Recent advances in CNS P2X7 physiology and pharmacology: Focus on neuropsychiatric disorders
Bhattacharya, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00030 · Cited by 115
Central nervous system myeloid cells as drug targets: current status and translational challenges
Biber, K. P. H., Möller, T., Boddeke, E., & Prinz, M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.14 · Cited by 111
P2X7 Receptor as a Therapeutic Target
Marchi, E. D., Orioli, E., Ben, D. D., & Adinolfi, E. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.004 · Cited by 117
Ali, Z., Laurijssens, B. E., Ostenfeld, T., McHugh, S. M., Stylianou, A., Scott‐Stevens, P., Hosking, L. K., Dewit, O., Richardson, J. C., & Chen, C. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04320.x · Cited by 111
Csölle, C., Andó, R. D., Kittel, Á., Gölöncsér, F., Baranyi, M., Soproni, K., Zelena, D., Haller, J., Németh, T., Mócsai, A., et al. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001933 · Cited by 108
Boucher, A. A., Arnold, J. C., Hunt, G. E., Spiro, A., Spencer, J., Brown, C., McGregor, I. S., Bennett, M. R., & Kassiou, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.049 · Cited by 108
Subthreshold bipolarity: diagnostic issues and challenges
Nusslock, R., & Frank, E. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00957.x · Cited by 112
P2X and P2Y Receptors—Role in the Pathophysiology of the Nervous System
Puchałowicz, K., Tarnowski, M., Baranowska‐Bosiacka, I., Chlubek, D., & Dziedziejko, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151223672 · Cited by 115
Kohli, M. A., Salyakina, D., Pfennig, A., Lucae, S., Horstmann, S., Menke, A., Kloiber, S. M., Hennings, J. M., Bradley, B., Ressler, K. J., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.201 · Cited by 108
Jiang, L., Baldwin, J. M., Roger, S., & Baldwin, S. A. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00055 · Cited by 114
Association between depression and the Gln460Arg polymorphism of P2RX7 gene: A dimensional approach
Hejjas, K., Szekely, A., Domotor, E., Halmai, Z., Balogh, G., Schilling, B., Sarosi, A., Faludi, G., Sasvari‐Szekely, M., & Nemoda, Z. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30799 · Cited by 100
P2X7 Receptor: A Potential Therapeutic Target for Depression?
Deussing, J. M., & Arzt, E. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.07.005 · Cited by 97
Sillaber, I., Panhuysen, M., Henniger, M. S. H., Ohl, F., Kühne, C., Pütz, B., Pohl, T., Deussing, J. M., Páez-Pereda, M., & Holsboer, F. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1232-6 · Cited by 95
Purinergic receptors in psychiatric disorders
Krügel, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.032 · Cited by 96
Metzger, M. W., Walser, S. M., Aprile-Garcia, F., Dedic, N., Chen, A., Holsboer, F., ARZT, E. S., Wurst, W., & Deussing, J. M. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9546-z · Cited by 98
Soronen, P., Mantere, O., Melartin, T. K., Suominen, K. H., Vuorilehto, M. S., Rytsälä, H. J., Arvilommi, P., Holma, I. A. K., Holma, M., Jylhä, P. J., et al. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31179 · Cited by 92
Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders
Erhardt, A., Lucae, S., Unschuld, P. G., Ising, M., Kern, N., Salyakina, D., Lieb, R., Uhr, M., Binder, E. B., Keck, M. E., et al. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.11.016 · Cited by 88
Su, W.-J., Zhang, T., Jiang, C.-L., & Wang, W. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00412 · Cited by 84
Farooq, R. K., Tanti, A., Ainouche, S., Roger, S., Belzung, C., & Camus, V. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.07.016 · Cited by 83
Bhattacharya, A., Lord, B., Grigoleit, J., He, Y., Fraser, I. C., Campbell, S. N., Taylor, N., Aluisio, L. E., O’Connor, J. C., Papp, M., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0141-6 · Cited by 84
CANDID: a flexible method for prioritizing candidate genes for complex human traits
Hutz, J., Kraja, A. T., McLeod, H. L., & Province, M. A. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20346 · Cited by 82
ATP and acetylcholine, equal brethren.
Zimmermann, H. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.09.004 · Cited by 83
Roger, S., Gillet, L., Baroja‐Mazo, A., Surprenant, A., & Pelegrı́n, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.053082 · Cited by 76
Microglial-driven changes in synaptic plasticity: A possible role in major depressive disorder
Innes, S. C., Pariante, C. M., & Borsini, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.12.233 · Cited by 77
Astrocytes and major depression: The purinergic avenue
Zhao, Y. F., Verkhratsky, A., Tang, Y. C., & Illés, P. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109252 · Cited by 76
Hung, C., Breen, G. D., Czamara, D., Corre, T., Wolf, C., Kloiber, S. M., Bergmann, S., Craddock, N. J., Gill, M., Holsboer, F., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0334-3 · Cited by 71
Interleukin-1 β-Targeted Treatment Strategies in Inflammatory Depression: Toward Personalized Care
Ellul, P., Boyer, L., Groc, L., Leboyer, M., & Fond, G. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12656 · Cited by 65
P2 Receptor Signaling in Neurons and Glial Cells of the Central Nervous System
Köles, L., Leichsenring, A., Rubini, P., & Illés, P. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385526-8.00014-x · Cited by 71
Ketamine, magnesium and major depression – From pharmacology to pathophysiology and back
Murck, H. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.02.015 · Cited by 72
Kimura, L. F., Novaes, L. S., Picolo, G., Munhoz, C. D., Cheung, C. W., & Camarini, R. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15584 · Cited by 74
Anisman, H., Merali, Z., & Stead, J. D. H. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.001 · Cited by 71
Territo, P. R., & Zarrinmayeh, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.617036 · Cited by 73
P2RX7: A bipolar and unipolar disorder candidate susceptibility gene?
Green, E., Grozeva, D., Raybould, R., Elvidge, G. P., MacGregor, S., Craig, I., FARMER, A. E., McGuffin, P., Forty, L., Jones, L. A., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30931 · Cited by 66
Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals
Rivera, M., Locke, A. E., Corre, T., Czamara, D., Wolf, C., Ching-López, A., Milaneschi, Y., Kloiber, S. M., Cohen‐Woods, S., Rucker, J., et al. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.116.183475 · Cited by 70
Purinergic Signaling and Related Biomarkers in Depression
Bartoli, F., Burnstock, G., Crocamo, C., & Carrà, G. (2020) · Brain Sciences · doi:10.3390/brainsci10030160 · Cited by 64
New Therapeutic Targets for Mood Disorders
Machado‐Vieira, R., Salvadore, G., Diazgranados, N., Ibrahim, L. A., Latov, D. R., Wheeler‐Castillo, C., Baumann, J., Henter, I. D., & Zarate, C. A. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.65 · Cited by 64
The P2RX7 polymorphism rs2230912 is associated with depression: A meta-analysis
Czamara, D., Müller-Myhsok, B., & Lucae, S. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.003 · Cited by 60
Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System
Liberman, A. C., Trías, E., Chagas, L. D. S., Trindade, P., Pereira, M. D. S., Refojo, D., Hedin‐Pereira, C., & Serfaty, C. A. (2018) · NeuroImmunoModulation · doi:10.1159/000494761 · Cited by 62
Metzger, M. W., Walser, S. M., Dedic, N., Aprile-Garcia, F., Jakubcakova, V., Adamczyk, M., Webb, K. J., Uhr, M., Refojo, D., Schmidt, M. V., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3487-16.2017 · Cited by 59
Understanding the role of P2X7 in affective disorders—are glial cells the major players?
Stokes, L., Spencer, S. J., & Jenkins, T. A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00258 · Cited by 59
Czibere, L., Baur, L. A., Wittmann, A., Gemmeke, K., Steiner, A., Weber, P., Pütz, B., Ahmad, N., Bunck, M., Graf, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023604 · Cited by 61
Inhibition of P2X7 receptors by divalent cations: old action and new insight
Jiang, L. (2008) · European Biophysics Journal · doi:10.1007/s00249-008-0315-y · Cited by 57
The role of purinergic signaling in depressive disorders.
Sperlágh, B., Csölle, C., Andó, R. D., Gölöncsér, F., Kittel, Á., & Baranyi, M. (2012) · PubMed · Cited by 56
Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms
Halmai, Z., Dome, P., Vereczkei, A., Abdul-Rahman, O., Szekely, A., Gonda, X., Faludi, G., Sasvari-Szekely, M., & Nemoda, Z. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.033 · Cited by 55
Ma, M., Ren, Q., Zhang, J.-C., & Hashimoto, K. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.1.31 · Cited by 55
Bradley, H., Baldwin, J. M., Goli, G. R., Johnson, B., Zou, J., Sivaprasadarao, A., Baldwin, S. A., & Jiang, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211284 · Cited by 56
Metadata
- Authors
- Lucae, S., Salyakina, D., Barden, N., Harvey, M., Gagné, B., Labbé, M., Binder, E. B., Uhr, M., Paez-Pereda, M., Sillaber, I., Ising, M., Brückl, T., Lieb, R., Holsboer, F., & Müller-Myhsok, B.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Müller-Myhsok, Bertram
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-05
- Volume
- 15
- Issue
- 16
- Pages
- 2438-2445
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2172099127
- Cited by
- 261
- References
- 49
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 4 · 2023: 10 · 2022: 10 · 2021: 12 · 2020: 8 · 2019: 6 · 2018: 15 · 2017: 9 · 2016: 10 · 2015: 16 · 2014: 17 · 2013: 18 · 2012: 23
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Human Molecular Genetics (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Bundesministerium für Bildung und Forschung (01GS0481)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- P2X7 receptor, major depressive disorder, single nucleotide polymorphisms, genetic susceptibility, microglia, bipolar disorder, non-synonymous variants
- MeSH terms
- Adult, Major Depressive Disorder, Female, Gene Frequency, Genotype, Haplotypes, Humans, Genetic Linkage, Male, Middle Aged, Phenotype, Recurrence, Linkage Disequilibrium, Logistic Models, Case-Control Studies, Age of Onset, Receptors, Purinergic P2, Polymorphism, Single Nucleotide, Receptors, Purinergic P2X7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review